JNJ
Johnson & Johnson
Company · XNYS · US · USD
Market price
$259.62
+$38.19 (+17.25%) · 3 months
| Date and time | Price |
|---|---|
| May 11, 2026 | $221.43 |
| May 12, 2026 | $222.19 |
| May 13, 2026 | $225.68 |
| May 14, 2026 | $230.96 |
| May 15, 2026 | $231.86 |
| May 18, 2026 | $228.92 |
| May 19, 2026 | $228.96 |
| May 20, 2026 | $231.44 |
| May 21, 2026 | $229.26 |
| May 22, 2026 | $232.68 |
| May 26, 2026 | $230.18 |
| May 27, 2026 | $231.31 |
| May 28, 2026 | $230.82 |
| May 29, 2026 | $225.29 |
| Jun 1, 2026 | $223.51 |
| Jun 2, 2026 | $222.92 |
| Jun 3, 2026 | $223.57 |
| Jun 4, 2026 | $228.27 |
| Jun 5, 2026 | $232.89 |
| Jun 8, 2026 | $232.16 |
| Jun 9, 2026 | $236.90 |
| Jun 10, 2026 | $238.52 |
| Jun 11, 2026 | $238.31 |
| Jun 12, 2026 | $240.83 |
| Jun 15, 2026 | $235.66 |
| Jun 16, 2026 | $235.19 |
| Jun 17, 2026 | $233.83 |
| Jun 18, 2026 | $228.30 |
| Jun 22, 2026 | $231.29 |
| Jun 23, 2026 | $239.15 |
| Jun 24, 2026 | $241.02 |
| Jun 25, 2026 | $244.84 |
| Jun 26, 2026 | $254.41 |
| Jun 29, 2026 | $258.51 |
| Jun 30, 2026 | $253.91 |
| Jul 1, 2026 | $253.13 |
| Jul 2, 2026 | $262.94 |
| Jul 6, 2026 | $259.33 |
| Jul 7, 2026 | $267.24 |
| Jul 8, 2026 | $263.33 |
| Jul 9, 2026 | $259.11 |
| Jul 10, 2026 | $257.20 |
| Jul 13, 2026 | $257.77 |
| Jul 14, 2026 | $253.77 |
| Jul 15, 2026 | $246.99 |
| Jul 16, 2026 | $249.59 |
| Jul 17, 2026 | $253.02 |
| Jul 20, 2026 | $248.82 |
| Jul 21, 2026 | $250.73 |
| Jul 22, 2026 | $255.69 |
| Jul 23, 2026 | $259.39 |
| Jul 24, 2026 | $263.44 |
| Jul 27, 2026 | $265.95 |
| Jul 28, 2026 | $266.68 |
| Jul 29, 2026 | $265.66 |
| Jul 30, 2026 | $255.88 |
| Jul 31, 2026 | $256.41 |
| Aug 3, 2026 | $254.41 |
| Aug 4, 2026 | $254.99 |
| Aug 5, 2026 | $257.62 |
| Aug 6, 2026 | $257.14 |
| Aug 7, 2026 | $259.28 |
| Aug 10, 2026 | $259.62 |
- Period change
- +17.25%
- Period low
- $221.43
- Period high
- $267.24
- Observations
- 63
- Updated
- Aug 10, 2026, 6:25 PM
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Company websiteClassifications
- Biotechnology · Biotech
- Consumer staple goods · Necessities
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNYS
- Operating market
- XNYS
- Country
- US
- Currency
- USD
- Market capitalization
- $617,777,505,340.95
- Employees
- 140.8K